Stuttgart - Delayed Quote • EUR BioXcel Therapeutics Inc. (US09075P1057.SG) Follow Compare 0.3289 +0.0003 +(0.09%) At close: January 17 at 11:47:07 AM GMT+1 Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for US09075P1057.SG 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: US09075P1057.SG View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations BioXcel Therapeutics (BTAI) Moves to Buy: Rationale Behind the Upgrade BioXcel Therapeutics Inc (BTAI) Q3 2024 Earnings Call Highlights: Strategic Trials and ... Q3 2024 BioXcel Therapeutics Inc Earnings Call BioXcel Therapeutics, Inc. (BTAI) Reports Q3 Loss, Lags Revenue Estimates Will BioXcel Therapeutics, Inc. (BTAI) Report Negative Q3 Earnings? What You Should Know BioXcel Therapeutics (BTAI) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now Q2 2024 BioXcel Therapeutics Inc Earnings Call BioXcel Therapeutics, Inc. (BTAI) Reports Q2 Loss, Tops Revenue Estimates BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q1 2024 Earnings Call Transcript Q1 2024 BioXcel Therapeutics Inc Earnings Call BioXcel Therapeutics Full Year 2023 Earnings: Revenues Disappoint